Abstract: Syntheses of a variant of myo-inositol-containing compounds are discussed and described, including glycan phosphatidylinositol structures found on various cell surfaces and believed to play important roles in the life cycles of tropical parasites (Trypanosoma and Leishmania) and in the action of insulin, and phosphatidyl inositol phosphates, known signal substances in a number of biological events. The resolution of myo-inositol is performed using camphor acetals and the phosphohester linkages are introduced using H-phosphonates.
myo-Inositol appears widely in Nature, most frequently as phosphorylated or phospholipid derivatives, but 0-methyl and glycosyl inositols have also been identified and synthesized (ref.
1 and 2). The discovery that inositol derivatives containing phosphates, phospholipids, glycans or glycan hund prciteins are involved or act as "second messengers" in various cell regulation systems, has dramatically increased the interests in these compounds (ref. 3 and 4) . Most eukaryotic cells utilize glycosyl phosphatidylinositols (GPIs) to anchor proteins to the cell membrane. Partial structural data, accumulated for over 100 GPI membrane-anchored proteins from a variety of organisms, have led to the proposal of the generalized anchor structure depicted in Fig. 1 . (Fig. 2) , and the Thy-1 glycoprotein anchor from rat brain (ref. 7). We are now synthesizing parts of the Leishmania structure. Parts of the structures of Trypanosoma (ref. A phospho-oligosacharide has been proposed as a "second messenger" of insulin (ref. 12) . It is believed to be structurally related to the glycolipid part of the glycosyl-phosphatidylinositol anchors. The biologically active inositol phosphoglycan (IPG) is generated by a specific phospholipase. The structure of this IPG has not been determined, but evidence indicates the presence of myo-inositol glycosidically linked to a non-acetylated glucosamine unit, which itself is coupled to an oligosaccharide (Fig. 3) . Biological results have indicated that it is probably the cyclic phosphate (compound 2. Fig. 3 ) that mediates the action of insulin (ref.
13a). IPG structures are also known to be generated in response to growth factors. myo-inositol derivative 5 was achieved in two steps. Glycosylation of 4 with 5 gave the protected compound 6 in moderate yield. Several other glycosylation methods were tried, but gave many byproducts and lower yields. (Fig. 4) is believed to initiate actin polymerisation in neutrophiles, respiratory burst, protein synthesis, secretion and glucose metabolism. PIP3 has been synthesized by other groups (ref. 16 and 17) . 
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Scheme 3 The di-acylglycerol derivative U was synthesized, using known procedures, from the commercially available glycerol derivative u1 (Scheme 4 The myo-inositol and glycerol derivatives 9 and 11 were connected by the H-phosphonate method, developed in our laboratories (ref. 19) . By the use of this method, both the oxygen compound U and the sulfur analogue 14 could be synthesized. Deprotection to compound fi using TMSBr, which will remove both the benzyl esters and MOM-ethers is still under investigation. Other published methods (ref. 16 and 17) , involve at least a two step procedure.
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